56 results
DEFA14A
ATOS
Atossa Therapeutics Inc
14 Sep 21
Additional proxy soliciting materials
4:12pm
Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant … biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
28 Jun 23
Atossa Therapeutics Announces $10M Stock Repurchase Program
9:01am
. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology … . is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast
DEFA14A
ATOS
Atossa Therapeutics Inc
11 May 21
Additional proxy soliciting materials
4:07pm
Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant … . (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
9 May 22
Atossa Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines … and develop innovative medicines in oncology and infectious diseases with a current focus on breast cancer and COVID-19. For more information, please
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
12 Mar 24
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
8:30am
— Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical stage biopharmaceutical company developing innovative medicines … Therapeutics
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet
8-K
EX-99.1
f88df7k3ubv
13 May 20
Atossa Therapeutics Announces First Quarter 2020 Financial Results and Provides Company Update on COVID-19 HOPE and Endoxifen Programs
9:30am
8-K
EX-99.1
tjhelyo3rmpnz2g3m3
14 May 21
Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
9:15am
8-K
EX-99.1
1imon
31 Mar 21
Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update
9:01am
8-K
EX-99.1
7iyuc
13 Nov 20
Atossa Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
9:30am
8-K
EX-99.1
c8v it6hebd9ghuz
15 Nov 21
Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
9:25am
8-K
EX-99.1
qzuwgwlz9pxfgbno dji
7 Nov 22
Atossa Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
i37rag16a ofy0hdpxzn
13 Aug 20
Atossa Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
9:30am
8-K
EX-99.1
a72b oo8gwjzvu10
13 Aug 21
Atossa Therapeutics Announces Second Quarter 2021 Financial Results - Provides Corporate Update and Information about Upcoming Stockholder Meeting
9:30am
8-K
EX-99.1
7lbxl
8 Aug 22
Atossa Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
3t652 6ai62q
15 May 23
Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
9:10am
8-K
EX-99.1
79lhan2vg0wf7gzt
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
egs7f9vlzzlj9virl
14 Aug 23
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
8:30am
8-K/A
EX-99.1
a4rqq
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
7:18pm
8-K
EX-99.1
ww1ta7l0ugn x1u51vw
13 Nov 23
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
9:00am
8-K
EX-99.1
xiu8965dhhm47xvtm9
13 Mar 13
Atossa Genetics Announces National
12:00am